Susquehanna International Group, LLP Vaxxinity, Inc. Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.7 - $1.31 $10,336 - $19,343	14,766 New	14,766 $12,000
Q2 2023 Aug 11, 2023	SELL	$1.73 - $2.79 $504,677 - $813,901	-291,721 Reduced 95.92%	12,411 $31,000
Q1 2023 May 16, 2023	BUY	$1.43 - $4.24 $434,908 - $1.29 Million	304,132 New	304,132 $690,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.